Hosted on MSN7m
Viking Therapeutics Starts Mid-Stage Study on Oral Weight-Loss Drug
Viking Therapeutics VKTX announced that it has started the phase II VENTURE-Oral Dosing study to evaluate the safety and ...
Yahoo Finance6m
MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR
ANDOVER, Mass. & HAIFA, Israel, January 09, 2025--(BUSINESS WIRE)--MeMed, a leader in host-response diagnostics, today ...